Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)

被引:5
|
作者
Puleo, Christopher W. [1 ]
Ayers, Colby R. [2 ]
Garg, Sonia [2 ]
Neeland, Ian J. [2 ]
Lewis, Alana A. [2 ]
Pandey, Ambarish [2 ]
Drazner, Mark H. [2 ]
de Lemos, James A. [2 ]
机构
[1] Ochsner Med Ctr, Heart & Vasc Inst, 1514 Jefferson Highway, New Orleans, LA 70121 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
biostatistics; cardiology; heart failure; NATRIURETIC PEPTIDE LEVELS; LEFT-VENTRICULAR HYPERTROPHY; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; GENERAL-POPULATION; PROGNOSTIC VALUE; IMPACT; ASSAY; MORTALITY; FAILURE;
D O I
10.2217/bmm-2021-0055
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) associate with structural heart disease and heart failure risk in individuals without known cardiovascular disease (CVD). However, few data are available regarding whether factors influencing levels of these two biomarkers are similar or distinct. We performed serial measurement of NT-proBNP and hs-cTnT in a contemporary multiethnic cohort with extensive phenotyping, with the goal of identifying their respective biological determinants in a population without known or suspected CVD. Methods: We evaluated 1877 participants of the Dallas Heart Study who had NT-proBNP and hs-cTnT measured and were free from clinical CVD at the each of its two examinations (2000-2002 and 2007-2009). Variables collected included demographic and risk factors, high-sensitivity C-reactive protein, body composition via dual-energy x-ray absorptiometry, coronary artery calcium by computed tomography, and cardiac dimensions and function by cardiac MRI. Linear regression was used to identify associations of these factors with each biomarker at baseline and with changes in biomarkers over follow-up. Results: NT-proBNP and hs-cTnT were poorly correlated at baseline (Spearman rho 0.083, p = 0.015), with only moderate correlation between change values (rho 0.18, p < 0.001). hs-cTnT positively associated and NT-proBNP inversely associated with male gender and black race. At baseline, both NT-proBNP and hs-cTnT associated with left ventricular end-diastolic volume and wall thickness, but only NT-proBNP associated with left atrial size. Changes in cardiac dimensions between phases were more strongly associated with changes in NT-proBNP than hs-cTnT. NT-proBNP was more strongly associated with high-sensitivity C-reactive protein and measures of body composition than hs-cTnT. Conclusion: Among individuals without CVD in the general population, NT-proBNP and hs-cTnT are nonredundant biomarkers that are differentially associated with demographic and cardiac factors. These findings indicate that hs-cTnT and NT-proBNP may reflect different pathophysiological pathways.
引用
收藏
页码:1487 / 1498
页数:12
相关论文
共 50 条
  • [21] Risk stratification by high-sensitivity troponin T and NT-proBNP prior to major noncardiac surgery
    Buse, Lurati G.
    Weber, M.
    Luchner, A.
    Seeberger, M.
    Muller, C.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 56 - 56
  • [22] The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population
    Potter, Julia M.
    Simpson, Aaron J.
    Kerrigan, Jennifer
    Southcott, Emma
    Salib, Marie M.
    Koerbin, Gus
    Hickman, Peter E.
    CLINICAL BIOCHEMISTRY, 2017, 50 (15) : 813 - 815
  • [23] Individual and Joint Associations of High-Sensitivity Troponin I and High-Sensitivity Troponin T with Cardiac Phenotypes and Outcomes in the General Population: An Analysis From the Dallas Heart Study
    Vigen, Rebecca
    Ayers, Colby
    Berry, Jarett
    Rohatgi, Anand
    Nambi, Vijay
    Ballantyne, Christie M.
    Omland, Torbjorn
    de Filippi, Christopher R.
    de Lemos, James
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (13):
  • [24] Factors Associated With Changes in High Sensitivity Troponin and NT-proBNP in Response to Intensive Blood Pressure Lowering in SPRINT
    Nguyen, Thomas T.
    Varghese, Achsah
    Dalmacy, Djhenne
    Ascher, Simon
    Ballantyne, Christie M.
    Nambi, Vijay
    De Lemos, James A.
    Berry, Jarett D.
    CIRCULATION, 2023, 148
  • [25] High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study
    Tynkkynen, Juho
    Hernesniemi, Jussi A.
    Laatikainen, Tiina
    Havulinna, Aki S.
    Salo, Perttu
    Blankenberg, Stefan
    Zeller, Tanja
    Salomaa, Veikko
    JOURNAL OF NEUROLOGY, 2017, 264 (03) : 503 - 511
  • [26] High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer’s disease: the FINRISK Study
    Juho Tynkkynen
    Jussi A. Hernesniemi
    Tiina Laatikainen
    Aki S. Havulinna
    Perttu Salo
    Stefan Blankenberg
    Tanja Zeller
    Veikko Salomaa
    Journal of Neurology, 2017, 264 : 503 - 511
  • [27] Variation of NT-proBNP and High-Sensitivity Cardiac Troponin T Across Levels of Estimated Glomerular Filtration Rate: The SPRINT Trial
    Bansal, Nisha
    Katz, Ronit
    Seliger, Stephen
    deFilippi, Christopher
    Wettersten, Nicholas
    de Lemos, James A.
    Christenson, Robert
    Killeen, Anthony A.
    Berry, Jarett D.
    Shlipak, Michael G.
    Ix, Joachim H.
    CIRCULATION, 2024, 149 (12) : 967 - 969
  • [28] ST2, NT-proBNP and high-sensitivity troponin T predict death and hospitalization in elderly patients with heart failure
    Aimo, Alberto
    Januzzi, James L.
    Vergaro, Giuseppe
    Richards, Mark
    Lam, Carolyn
    Latini, Roberto
    Meessen, Jennifer
    Anand, Inder S.
    Cohn, Jay N.
    Gravning, Jorgen
    Ueland, Thor
    Nymo, Stale
    Gullestad, Lars
    Aukrust, Pal
    Brunner-la Rocca, Hans-Peter
    Bayes-Genis, Antoni
    Lupon, Josep
    De Boer, Rudolf A.
    Yoshihisa, Akiomi
    Takeishi, Yasuchika
    Egstrup, Michael
    Gustafsson, Ida
    Gaggin, Hanna K.
    Eggers, Kai M.
    Huber, Kurt
    Tentzeris, Ioannis
    Gamble, Greg D.
    Ling, Lieng H.
    Sim, David
    Leong, Kui Tong Gerard
    Yeo, Poh Shuah Daniel
    Ong, Hean Yee
    Jaufeerally, Fazlur
    Ng, Tze P.
    Poppe, Katrina
    Lund, Mayanna
    Devlin, Gerry
    Troughton, Richard
    Doughty, Robert N.
    Ripoli, Andrea
    Passino, Claudio
    Emdin, Michele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J120 - J120
  • [29] High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
    Aimo, Alberto
    Januzzi, James L., Jr.
    Vergaro, Giuseppe
    Ripoli, Andrea
    Latini, Roberto
    Masson, Serge
    Magnoli, Michela
    Anand, Inder S.
    Cohn, Jay N.
    Tavazzi, Luigi
    Tognoni, Gianni
    Gravning, Jorgen
    Ueland, Thor
    Nymo, Stale H.
    Brunner-La Rocca, Hans-Peter
    Bayes-Genis, Antoni
    Lupon, Josep
    de Boer, Rudolf A.
    Yoshihisa, Akiomi
    Takeishi, Yasuchika
    Egstrup, Michael
    Gustafsson, Ida
    Gaggin, Hanna K.
    Eggers, Kai M.
    Huber, Kurt
    Tentzeris, Loannis
    Tang, W. H. Wilson
    Grodin, Justin L.
    Passino, Claudio
    Emdin, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 277 : 166 - 172
  • [30] Blood Pressure Variability Is Associated with Risk of Heart Failure, Elevated NT-proBNP, and High-Sensitivity Troponin: Results from MESA
    Nuyujukian, Daniel S.
    Zhou, Jin
    Koska, Juraj
    Nwabuo, Chike
    Bertoni, Alain
    Shea, Steven
    Reaven, Peter
    DIABETES, 2022, 71